ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation

Yan, Meiling; Li, Lun; Wang, Qing; Shao, Xiaoqi; Luo, Qingmao; Liu, Suping; Li, Yun; Wang, Dongwei; Zhang, Yue; Diao, Hongtao; Rong, Xianglu; Guo, Jiao*广东药学院
Biomedicine and Pharmacotherapy2022-4DOI: 10.1016/j.biopha.2022.112709
12被引22阅读
引用收藏
分享

摘要

Background: Fufang Zhenzhu Tiao Zhi (FTZ) formula is a Chinese herbal preparation used in the clinical treatment of disorders of glucolipid metabolism. Given its effective actions on the regulation of lipid dysfunction and its anti-inflammatory and antioxidative effects, we designed this study to investigate the cardioprotective effect and possible mechanism of FTZ in diabetic cardiomyopathy (DCM) mice. @@@ Methods: FTZ was administered to diabetic mice by oral gavage daily at a dose of 1.2 g/kg or 2.4 g/kg body-weight for 8 weeks. Doppler echocardiography, H&E, and WGA staining were used to evaluate cardiac function and structure in the mice. The levels of proinflammatory cytokines and lipids in serum were detected with corresponding commercial kits. Immunofluorescence staining and flow cytometry were used to detect oxidation damage and pyroptosis in myocardial cells. RT-PCR and western blotting were used to analyze the protein and mRNA expression levels of NLRP3 inflammasome-related genes. @@@ Results: Our study indicated that FTZ improved cardiac function, attenuated heart hypertrophy, improved serum lipid and proinflammatory cytokine levels, and restrained oxidative stress and NLRP3 inflammasome-induced inflammatory activities in diabetic mouse hearts. The in vitro data suggested that FTZ suppressed intercellular lipid accumulation as well as palmitic acid (PA)-induced oxidative stress and NLRP3 inflammasome-dependent pyroptosis in cardiomyocytes. @@@ Conclusion: Our present findings indicate that FTZ inhibits DCM by inhibiting both oxidative stress and NLRP3 inflammasome activation induced by cardiac lipotoxicity.

学科与关键词

关键词
Fufang Zhenzhu TiaozhiDiabetic cardiomyopathyLipotoxicityOxidative stressNLRP3 inflammasome
相关
加载中…
  • The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice
    Yan, Meiling; Liu, Suping; Zeng, Wenru; Guo, Qiaoling; Mei, Yu; Shao, Xiaoqi; Su, Liyan; Liu, Zhou; Zhang, Yue; Wang, Lexun; Diao, Hongtao; Rong, Xianglu; Guo, JiaoBiomedicine and Pharmacotherapy, 2023, 164: 114919.被引 1
  • Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis
    Shao, Xiaoqi; Huang, Bingying; Tan, Huiling; Wang, Ruonan; Huang, Xueying; Diao, Hongtao; Cheng, Jiawen; Sun, Mengxian; Wang, Dongwei; Wu, Kaili; Yan, Meiling; Rong, Xianglu; Zhang, Yue; Guo, JiaoEvidence-based Complementary and Alternative Medicine, 2022, 2022: 4752360.
  • Chinese medicine Fufang Zhenzhu Tiaozhi capsule ameliorates coronary atherosclerosis in diabetes mellitus-related coronary heart disease minipigs
    Wang, Lexun; Zhang, Dongxing; Zhan, Wenjing; Zeng, Zhihuan; Yin, Jianying; Wang, Ke; Wang, Hong; Song, Lixia; Gu, Zhanhui; Guo, Caijuan; Zhong, Qin; Wang, Weixuan; Rong, Xianglu; Bei, Weijian; Guo, JiaoBiomedicine and Pharmacotherapy, 2022, 156: 113831.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2022-04
卷期
第 148 卷
页码
112709
DOI
10.1016/j.biopha.2022.112709
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
Key Project of the National Natural Science Foundation of China [81830113]; National Key R&D Plan "Research on Modernization of Traditional Chinese Medicine" [2018YFC1704200]; Major Basic and Applied Basic Research Projects of Guangdong Province of China [2019B030302005]; Youth Innovative Talents Project of Guangdong Provincial Department Education [51309404]

作者

  • Y

    Yan, Meiling (第一作者)

    guangdong pharmaceut univ

  • L

    Li, Lun

    guangdong pharmaceut univ

查看全部 12 位作者收起作者
  • W

    Wang, Qing

    guangdong pharmaceut univ

  • S

    Shao, Xiaoqi

    guangdong pharmaceut univ

  • L

    Luo, Qingmao

    guangdong pharmaceut univ

  • L

    Liu, Suping

    guangdong pharmaceut univ

  • L

    Li, Yun

    guangdong pharmaceut univ

  • W

    Wang, Dongwei

    guangdong pharmaceut univ

  • Z

    Zhang, Yue

    guangdong pharmaceut univ

  • D

    Diao, Hongtao

    guangdong pharmaceut univ

  • R

    Rong, Xianglu

    guangdong pharmaceut univ

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417